Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4945 total record number 0 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 307 out of 495
4945 citations found

Product: Toxin B from Clostridium difficile

  • NOVEL APPROACHES TO ULTRASENSITIVE TOXIN DETECTION:

    … cell index (nCI) has dropped by 30% is considered a positive time step (PST) which in turn is used to calculate toxin concentrations in samples by comparison to a standard curve generated with buffer spiked with purified toxin B (List Biological Laboratories [Campbell, CA …

Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models

Bruxelle, JF;Mizrahi, A;Hoys, S;Collignon, A;Janoir, C;Pchin, S;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Cryptococcus gattii Capsule Blocks Surface Recognition Required for Dendritic Cell Maturation Independent of Internalization and Antigen Processing

Huston, SM;Ngamskulrungroj, P;Xiang, RF;Ogbomo, H;Stack, D;Li, SS;Timm-McCann, M;Kyei, SK;Oykhman, P;Kwon-Chung, KJ;Mody, CH;

Product: Unspecified List Labs LPS

  • DC cytokine analysis:

    To examine intracellular cytokine expression, iDC were cultured in the presence or absence of the encapsulated strains R265 (R265mDC) and cap59R (cap59RmDC), the acapsular strain cap59D (cap59DmDC), or 1 mg/ml LPS-matured DC (LPSmDC) at a 1:10 ratio (DC/C. gattii) (List Biological Laboratories, Campbell, CA).

    Author did not specify which List Labs LPS product was utilized in their research.  List Labs provides the following LPS products:  https://listlabs.com/product-information/lipopolysaccharides/

Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4

Laplante, P;Fuentes, R;Salem, D;Subang, R;Gillis, MA;Hachem, A;Farhat, N;Qureshi, ST;Fletcher, CA;Roubey, RA;Merhi, Y;Thorin, ;Levine, JS;Mackman, N;Rauch, J;

Product: LPS from Escherichia coli O111:B4

Product: LPS from Escherichia coli O111:B4

Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis

Chen, SJ;Huang, SH;Chen, JW;Wang, KC;Yang, YR;Liu, PF;Lin, GJ;Sytwu, HK;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Molecular Dynamics of Multivalent Soluble Antigen Arrays Support a Two-Signal Co-delivery Mechanism in the Treatment of Experimental Autoimmune Encephalomyelitis

Hartwell, BL;Smalter Hall, A;Swafford, D;Sullivan, BP;Garza, A;Sestak, JO;Northrup, L;Berkland, C;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo

Velzquez, F;Grodecki-Pena, A;Knapp, A;Salvador, AM;Nevers, T;Croce, KJ;Alcaide, P;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

CD11b(+) Mononuclear Cells Mitigate Hyperoxia-Induced Lung Injury in Neonatal Mice

Eldredge, LC;Treuting, PM;Manicone, AM;Ziegler, SF;Parks, WC;McGuire, JK;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Plasmacytoid dendritic cells are dispensable for noninfectious intestinal IgA responses in vivo

Moro-Sibilot, L;This, S;Blanc, P;Sanlaville, A;Sisirak, V;Bardel, E;Boschetti, G;Bendriss-Vermare, N;Defrance, T;Dubois, B;Kaiserlian, D;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • In vivo treatments:

    To deplete pDCs, BDCA2-DTR mice were injected i.p. with 20 ng/g of DT (List Biological Laboratories, Campbell, CA, USA) on day 0 (or day 1 for oral immunization), then every other day with 10 ng/g. DT-treated WT littermates were used as controls. …CD4+ T-cell depletion was controlled in blood at day 0 before starting DT treatment and at sacrifice.